MINERAL OIL, PETROLATUM

MINERAL OIL, PETROLATUM was reported 663 times

MINERAL OIL, PETROLATUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONJUNCTIVAL OPERATION 1 0.2000
1 KERATECTOMY 1 0.1667
2 LID MARGIN DISCHARGE 2 0.0741
3 PROPIONIBACTERIUM TEST POSITIVE 1 0.0588
4 TEAR BREAK UP TIME DECREASED 1 0.0455
5 EXFOLIATION SYNDROME 1 0.0385
6 ACUTE MYELOID LEUKAEMIA (IN REMISSION) 1 0.0294
7 PUNCTAL PLUG INSERTION 2 0.0286
8 EYE PROSTHESIS INSERTION 1 0.0256
9 BLADDER ULCER 1 0.0244
10 NEURILEMMOMA BENIGN 1 0.0208
11 DEAFNESS PERMANENT 4 0.0204
12 EYELASH HYPERPIGMENTATION 1 0.0200
13 BLEPHAROCHALASIS 1 0.0200
14 BENIGN NEOPLASM OF EYE 1 0.0200
15 GYNAECOLOGICAL EXAMINATION ABNORMAL 1 0.0192
16 POLYGLANDULAR AUTOIMMUNE SYNDROME TYPE II 1 0.0185
17 PULMONARY IMAGING PROCEDURE ABNORMAL 1 0.0179
18 KERATORHEXIS 2 0.0175
19 HORMONE REPLACEMENT THERAPY 1 0.0172
20 OCCUPATIONAL PROBLEM ENVIRONMENTAL 1 0.0169
21 ARCUS LIPOIDES 1 0.0159
22 PERIORBITAL PAIN 12 0.0142
23 AUTOPHONY 1 0.0133
24 MIXED DEAFNESS 1 0.0127
25 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 1 0.0125
26 VIITH NERVE INJURY 1 0.0123
27 POST PROCEDURAL ERYTHEMA 1 0.0112
28 PLANTAR FASCIAL FIBROMATOSIS 1 0.0112
29 CHIMERISM 1 0.0112
30 EYELID THICKENING 3 0.0105
31 OTOSCLEROSIS 1 0.0100
32 LAGOPHTHALMOS 4 0.0098
33 CORNEAL OPERATION 1 0.0097
34 PALATAL ULCER 1 0.0094
35 ADHESIOLYSIS 1 0.0093
36 CORNEAL EROSION 5 0.0093
37 DACRYOCANALICULITIS 1 0.0085
38 DERMATOPHYTOSIS OF NAIL 1 0.0084
39 FOREIGN BODY IN EYE 8 0.0083
40 BLEPHAROPLASTY 1 0.0082
41 ENDOCRINE OPHTHALMOPATHY 7 0.0081
42 BURKHOLDERIA TEST POSITIVE 1 0.0081
43 CORNEAL SCAR 4 0.0080
44 ANTI-THYROID ANTIBODY INCREASED 1 0.0079
45 INSTILLATION SITE DRYNESS 1 0.0078
46 EYELID OPERATION 2 0.0075
47 INSTILLATION SITE DISCOMFORT 1 0.0075
48 EYE COMPLICATION ASSOCIATED WITH DEVICE 2 0.0074
49 SUPERFICIAL INJURY OF EYE 8 0.0073
50 COCHLEA IMPLANT 1 0.0073
51 AUTOMATIC BLADDER 1 0.0072
52 OCULAR RETROBULBAR HAEMORRHAGE 1 0.0072
53 INSTILLATION SITE FOREIGN BODY SENSATION 1 0.0069
54 EYELID PAIN 14 0.0069
55 BASOSQUAMOUS CARCINOMA 1 0.0067
56 CONJUNCTIVAL SCAR 1 0.0066
57 CORNEAL ABRASION 9 0.0066
58 ENTROPION 1 0.0065
59 INTRAOCULAR PRESSURE FLUCTUATION 1 0.0051
60 OCULAR ROSACEA 1 0.0049
61 HERPES ZOSTER OPHTHALMIC 1 0.0049
62 THROMBOPHLEBITIS SEPTIC 1 0.0049
63 EXPOSURE TO FUNGUS 1 0.0047
64 CORNEAL INFECTION 1 0.0046
65 VERY LOW DENSITY LIPOPROTEIN INCREASED 1 0.0045
66 TYPE IIA HYPERLIPIDAEMIA 1 0.0043
67 FOREIGN BODY SENSATION IN EYES 27 0.0042
68 LACRIMATION DECREASED 2 0.0042
69 INSTILLATION SITE LACRIMATION 1 0.0041
70 CORNEAL DEGENERATION 1 0.0041
71 CORNEAL NEOVASCULARISATION 1 0.0040
72 INTRAOCULAR LENS IMPLANT 2 0.0040
73 BURNING FEET SYNDROME 1 0.0040
74 RIB DEFORMITY 1 0.0039
75 CHRONIC DISEASE 1 0.0039
76 GLAUCOMA SURGERY 1 0.0039
77 KERATOMILEUSIS 1 0.0039
78 INJURY CORNEAL 2 0.0038
79 CORNEAL TRANSPLANT 3 0.0038
80 DEPOSIT EYE 1 0.0037
81 CARDIAC SEPTAL HYPERTROPHY 1 0.0036
82 CHEMICAL BURNS OF EYE 1 0.0036
83 EPIRETINAL MEMBRANE 1 0.0036
84 ANAEMIA OF MALIGNANT DISEASE 1 0.0036
85 ORTHOSIS USER 1 0.0036
86 EYE ULCER 2 0.0035
87 MALIGNANT NEOPLASM OF EYE 1 0.0035
88 EYE DISCHARGE 35 0.0034
89 SPASMODIC DYSPHONIA 1 0.0033
90 IMPAIRED FASTING GLUCOSE 1 0.0033
91 TRICHIASIS 1 0.0031
92 EYE INFECTION VIRAL 1 0.0031
93 SCLERAL HYPERAEMIA 2 0.0029
94 CONJUNCTIVITIS BACTERIAL 1 0.0029
95 POSTERIOR CAPSULE OPACIFICATION 1 0.0029
96 EYE OPERATION 13 0.0028
97 HYPOGLYCAEMIA UNAWARENESS 1 0.0028
98 DRY AGE-RELATED MACULAR DEGENERATION 3 0.0027
99 LACRIMAL STRUCTURE INJURY 1 0.0027
100 CERVICAL POLYP 1 0.0026
101 EYE PAIN 146 0.0026
102 EYE INFECTION FUNGAL 1 0.0026
103 TRI-IODOTHYRONINE INCREASED 1 0.0025
104 GRANULOCYTE COUNT INCREASED 1 0.0025
105 BLOOD URIC ACID ABNORMAL 1 0.0025
106 ACOUSTIC NEUROMA 1 0.0024
107 NAIL OPERATION 1 0.0024
108 CORNEAL DYSTROPHY 1 0.0024
109 RAPID EYE MOVEMENTS SLEEP ABNORMAL 1 0.0024
110 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 1 0.0023
111 EYELID INFECTION 1 0.0023
112 HAEMORRHOID OPERATION 1 0.0022
113 MEIBOMIAN GLAND DYSFUNCTION 1 0.0022
114 PUNCTATE KERATITIS 2 0.0022
115 BODY MASS INDEX DECREASED 1 0.0022
116 OCULAR DISCOMFORT 24 0.0021
117 BLOOD PHOSPHORUS ABNORMAL 1 0.0021
118 INFUSION SITE HAEMATOMA 1 0.0021
119 TYPE V HYPERLIPIDAEMIA 1 0.0021
120 EYE IRRITATION 117 0.0020
121 ASTIGMATISM 3 0.0020
122 EYE COLOUR CHANGE 2 0.0020
123 GLARE 1 0.0019
124 KERATOPATHY 3 0.0019
125 GRIEF REACTION 1 0.0019
126 NIGHT BLINDNESS 3 0.0019
127 CORNEAL DISORDER 4 0.0018
128 PRODUCT CLOSURE ISSUE 1 0.0018
129 TENOSYNOVITIS STENOSANS 1 0.0018
130 EYE INFECTION BACTERIAL 1 0.0018
131 EUSTACHIAN TUBE DYSFUNCTION 1 0.0017
132 CORNEAL EPITHELIUM DEFECT 1 0.0017
133 EYE LASER SURGERY 1 0.0017
134 ERYTHEMA OF EYELID 9 0.0017
135 THYROID OPERATION 1 0.0016
136 POST PROCEDURAL INFLAMMATION 1 0.0016
137 INSTILLATION SITE PAIN 4 0.0016
138 EXCESSIVE CERUMEN PRODUCTION 1 0.0016
139 PHOTOPHOBIA 30 0.0016
140 EYELID IRRITATION 4 0.0016
141 PRODUCT CONTAMINATION PHYSICAL 4 0.0016
142 THYROXINE FREE INCREASED 1 0.0016
143 HYPERCHLORAEMIA 1 0.0016
144 MUCOSAL DISCOLOURATION 1 0.0016
145 DACRYOSTENOSIS ACQUIRED 2 0.0015
146 CELLULITIS STAPHYLOCOCCAL 1 0.0015
147 DEAFNESS NEUROSENSORY 5 0.0015
148 HEAD AND NECK CANCER 1 0.0015
149 INGROWN HAIR 1 0.0014
150 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 2 0.0014
151 ATYPICAL FEMUR FRACTURE 4 0.0014
152 GLASSY EYES 1 0.0014
153 MONOCYTE PERCENTAGE INCREASED 1 0.0014
154 MYCOBACTERIUM ABSCESSUS INFECTION 1 0.0014
155 PRODUCT DESIGN ISSUE 1 0.0014
156 PROTEUS INFECTION 1 0.0014
157 VITREOUS DETACHMENT 3 0.0014
158 GASTRIC MUCOSAL LESION 1 0.0014
159 TRAUMATIC FRACTURE 1 0.0014
160 OTITIS MEDIA ACUTE 1 0.0014
161 FIBROCYSTIC BREAST DISEASE 1 0.0014
162 CORNEAL DEPOSITS 1 0.0013
163 TENDON DISCOMFORT 1 0.0013
164 OCULAR HYPERAEMIA 62 0.0013
165 EYELID DISORDER 3 0.0013
166 ASTHENOPIA 7 0.0013
167 PRODUCT DROPPER ISSUE 1 0.0013
168 EYELID FUNCTION DISORDER 1 0.0013
169 EYE INFLAMMATION 12 0.0013
170 REACTION TO PRESERVATIVES 1 0.0012
171 OCULAR VASCULAR DISORDER 1 0.0012
172 ABNORMAL SENSATION IN EYE 5 0.0012
173 DRY EYE 58 0.0012
174 HORDEOLUM 5 0.0012
175 BLOOD ALBUMIN INCREASED 1 0.0011
176 ANAEMIA OF CHRONIC DISEASE 1 0.0011
177 LIQUID PRODUCT PHYSICAL ISSUE 8 0.0011
178 HAEMOCHROMATOSIS 1 0.0011
179 PERIORBITAL SWELLING 6 0.0011
180 LACRIMATION INCREASED 32 0.0011
181 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
182 RETINAL OEDEMA 2 0.0010
183 PCO2 DECREASED 1 0.0010
184 BLEPHARITIS 4 0.0010
185 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
186 BREAST ABSCESS 1 0.0010
187 EYELIDS PRURITUS 3 0.0010
188 SWELLING OF EYELID 6 0.0010
189 POST PROCEDURAL SWELLING 1 0.0009
190 PERIRECTAL ABSCESS 1 0.0009
191 EYE INFECTION 10 0.0009
192 BRAIN OPERATION 2 0.0009
193 T-CELL LYMPHOMA 1 0.0009
194 CARBON DIOXIDE DECREASED 1 0.0009
195 LUMBAR RADICULOPATHY 1 0.0009
196 OPTIC NERVE INJURY 1 0.0009
197 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
198 ESCHERICHIA TEST POSITIVE 1 0.0008
199 PULSE ABNORMAL 2 0.0008
200 EYELID SKIN DRYNESS 1 0.0008
201 HYPERAESTHESIA TEETH 1 0.0008
202 TESTICULAR SWELLING 1 0.0008
203 FACIAL PAIN 7 0.0008
204 MEAN CELL VOLUME INCREASED 2 0.0008
205 INFUSION SITE IRRITATION 1 0.0008
206 ABDOMINAL OPERATION 1 0.0008
207 RETINAL DISORDER 2 0.0008
208 HERPES OPHTHALMIC 1 0.0008
209 CORNEAL OPACITY 1 0.0007
210 MUCOUS MEMBRANE DISORDER 1 0.0007
211 ULCERATIVE KERATITIS 2 0.0007
212 IMMUNOGLOBULINS DECREASED 1 0.0007
213 TRACHEOSTOMY 1 0.0007
214 EYELID MARGIN CRUSTING 2 0.0007
215 EYELID PTOSIS 7 0.0007
216 DARK CIRCLES UNDER EYES 1 0.0007
217 COCCYDYNIA 1 0.0007
218 BLINDNESS TRANSIENT 5 0.0007
219 EYE INJURY 2 0.0007
220 EYE ALLERGY 1 0.0006
221 GASTROSTOMY 1 0.0006
222 CYSTITIS INTERSTITIAL 1 0.0006
223 EYE SWELLING 23 0.0006
224 EYELID OEDEMA 7 0.0006
225 BLOOD CALCIUM ABNORMAL 1 0.0006
226 MITRAL VALVE PROLAPSE 1 0.0006
227 SPINAL DEFORMITY 1 0.0006
228 BLOOD CHLORIDE INCREASED 1 0.0006
229 TREATMENT DELAYED 1 0.0006
230 VISION BLURRED 79 0.0006
231 PRODUCT USE COMPLAINT 9 0.0006
232 KYPHOSIS 1 0.0006
233 HISTOPLASMOSIS 1 0.0006
234 NASAL OEDEMA 1 0.0006
235 INTRAOCULAR PRESSURE INCREASED 7 0.0005
236 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
237 PRODUCT ADMINISTRATION ERROR 11 0.0005
238 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
239 OTOTOXICITY 1 0.0005
240 EYE PRURITUS 18 0.0005
241 LIVING IN RESIDENTIAL INSTITUTION 1 0.0005
242 EYE DISORDER 17 0.0005
243 OCULAR HYPERTENSION 1 0.0005
244 VISUAL ACUITY REDUCED 17 0.0005
245 HYPOGEUSIA 1 0.0005
246 JOINT NOISE 1 0.0005
247 MACULAR DEGENERATION 6 0.0005
248 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
249 IMPAIRED SELF-CARE 1 0.0005
250 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
251 EAR SWELLING 1 0.0005
252 CATARACT 28 0.0005
253 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
254 CHRONIC GASTRITIS 1 0.0004
255 RETINAL DETACHMENT 4 0.0004
256 SINUS PAIN 1 0.0004
257 MYOPIA 1 0.0004
258 EOSINOPHIL COUNT DECREASED 1 0.0004
259 LACUNAR INFARCTION 1 0.0004
260 IMPAIRED QUALITY OF LIFE 6 0.0004
261 GLAUCOMA 8 0.0004
262 VITREOUS FLOATERS 4 0.0004
263 NASAL POLYPS 2 0.0004
264 RETINAL TEAR 1 0.0004
265 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
266 STEM CELL TRANSPLANT 1 0.0004
267 PHYSICAL DECONDITIONING 1 0.0004
268 THERAPY PARTIAL RESPONDER 6 0.0004
269 BLOOD POTASSIUM ABNORMAL 1 0.0004
270 WHITE BLOOD CELL DISORDER 1 0.0004
271 LARYNGOSPASM 1 0.0004
272 BLOOD SODIUM INCREASED 1 0.0004
273 MIGRAINE WITH AURA 1 0.0004
274 SKIN WRINKLING 1 0.0004
275 RHINALGIA 1 0.0004
276 RED BLOOD CELL COUNT INCREASED 1 0.0004
277 PLEURITIC PAIN 1 0.0004
278 MACULAR OEDEMA 2 0.0004
279 MULTIPLE USE OF SINGLE-USE PRODUCT 2 0.0004
280 BLINDNESS UNILATERAL 5 0.0004
281 PRODUCT CONTAINER ISSUE 3 0.0003
282 SKIN HYPERPIGMENTATION 3 0.0003
283 STRABISMUS 1 0.0003
284 CATARACT OPERATION 2 0.0003
285 METABOLIC ENCEPHALOPATHY 1 0.0003
286 LOSS OF EMPLOYMENT 1 0.0003
287 KERATITIS 1 0.0003
288 DYSAESTHESIA 1 0.0003
289 PRE-EXISTING CONDITION IMPROVED 2 0.0003
290 IRIDOCYCLITIS 1 0.0003
291 PHOTOPSIA 2 0.0003
292 NON-CARDIAC CHEST PAIN 1 0.0003
293 PNEUMONIA VIRAL 1 0.0003
294 ENTERITIS 2 0.0003
295 LISTLESS 1 0.0003
296 OTITIS MEDIA 1 0.0003
297 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
298 EYE HAEMORRHAGE 4 0.0003
299 NEPHRITIS 1 0.0003
300 CLOSTRIDIAL INFECTION 1 0.0003
301 BLINDNESS 12 0.0003
302 DIABETIC RETINOPATHY 1 0.0003
303 EAR DISCOMFORT 3 0.0003
304 CERVICAL VERTEBRAL FRACTURE 1 0.0003
305 BLOOD CREATININE ABNORMAL 1 0.0003
306 HAIR GROWTH ABNORMAL 2 0.0003
307 DEVICE USE ISSUE 5 0.0003
308 THROMBOPHLEBITIS 1 0.0003
309 DRUG ADMINISTERED AT INAPPROPRIATE SITE 3 0.0003
310 MACULOPATHY 1 0.0003
311 PRODUCT SUPPLY ISSUE 2 0.0003
312 BONE LESION 1 0.0003
313 CHRONIC GRAFT VERSUS HOST DISEASE 1 0.0003
314 MONOCYTE COUNT INCREASED 1 0.0003
315 FAECES SOFT 2 0.0003
316 HYPERACUSIS 1 0.0003
317 MALNUTRITION 3 0.0003
318 THROAT CLEARING 1 0.0003
319 PROTEIN TOTAL DECREASED 1 0.0003
320 PEMPHIGOID 2 0.0003
321 OSTEOPENIA 4 0.0003
322 FACE INJURY 1 0.0003
323 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
324 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
325 FOREIGN BODY 1 0.0002
326 TRIGEMINAL NEURALGIA 1 0.0002
327 BURSITIS 3 0.0002
328 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
329 SUICIDAL BEHAVIOUR 1 0.0002
330 ONYCHOMADESIS 1 0.0002
331 BUNDLE BRANCH BLOCK LEFT 1 0.0002
332 ABSCESS LIMB 1 0.0002
333 PURULENT DISCHARGE 1 0.0002
334 VISUAL IMPAIRMENT 29 0.0002
335 DIPLOPIA 6 0.0002
336 DIVERTICULUM INTESTINAL 1 0.0002
337 ONYCHOMYCOSIS 1 0.0002
338 HAEMORRHAGIC ANAEMIA 1 0.0002
339 PHYSICAL DISABILITY 1 0.0002
340 SUSPECTED OFF LABEL USE 1 0.0002
341 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
342 ACCIDENTAL OVERDOSE 8 0.0002
343 TINNITUS 10 0.0002
344 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
345 CONJUNCTIVITIS 4 0.0002
346 PRODUCT PACKAGING ISSUE 2 0.0002
347 MEDICATION RESIDUE PRESENT 1 0.0002
348 GASTROINTESTINAL TOXICITY 1 0.0002
349 HUMERUS FRACTURE 1 0.0002
350 PHARYNGEAL SWELLING 2 0.0002
351 DISABILITY 4 0.0002
352 EXPIRED DRUG ADMINISTERED 1 0.0002
353 HYPERNATRAEMIA 1 0.0002
354 HEPATIC ENZYME ABNORMAL 1 0.0002
355 KLEBSIELLA INFECTION 1 0.0002
356 TASTE DISORDER 4 0.0002
357 DYSLIPIDAEMIA 1 0.0002
358 CEREBRAL ISCHAEMIA 1 0.0002
359 FAILURE TO THRIVE 1 0.0002
360 TENDERNESS 2 0.0002
361 TRANSFUSION 2 0.0002
362 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
363 SCRATCH 2 0.0002
364 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
365 PRODUCT RESIDUE PRESENT 1 0.0002
366 BRUXISM 1 0.0002
367 GINGIVITIS 1 0.0002
368 BIPOLAR DISORDER 2 0.0002
369 TIC 1 0.0002
370 JAW DISORDER 1 0.0002
371 HYPERKERATOSIS 1 0.0002
372 SKIN INFECTION 2 0.0002
373 STATUS EPILEPTICUS 2 0.0002
374 HEAD DISCOMFORT 3 0.0002
375 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
376 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
377 WRONG TECHNIQUE IN DRUG USAGE PROCESS 6 0.0002
378 DISCOMFORT 10 0.0002
379 PHARYNGITIS 2 0.0002
380 NASAL DRYNESS 1 0.0002
381 ROTATOR CUFF SYNDROME 2 0.0002
382 PROCTALGIA 1 0.0002
383 EAR PAIN 3 0.0002
384 INCORRECT PRODUCT STORAGE 2 0.0002
385 EXPIRED PRODUCT ADMINISTERED 5 0.0002
386 EXTRASYSTOLES 1 0.0001
387 THERMAL BURN 1 0.0001
388 DIVERTICULUM 1 0.0001
389 RETINAL HAEMORRHAGE 1 0.0001
390 RED BLOOD CELL COUNT DECREASED 4 0.0001
391 RASH PUSTULAR 1 0.0001
392 SURGERY 8 0.0001
393 ORAL DISORDER 1 0.0001
394 NASAL CONGESTION 8 0.0001
395 PSYCHIATRIC SYMPTOM 1 0.0001
396 IMMUNODEFICIENCY 2 0.0001
397 SNEEZING 3 0.0001
398 HYPOAESTHESIA ORAL 2 0.0001
399 ECONOMIC PROBLEM 2 0.0001
400 DRUG DISPENSING ERROR 2 0.0001
401 BOWEL MOVEMENT IRREGULARITY 1 0.0001
402 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
403 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
404 HIP FRACTURE 4 0.0001
405 MUSCLE DISORDER 1 0.0001
406 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 25 0.0001
407 BLOOD POTASSIUM INCREASED 2 0.0001
408 ABNORMAL FAECES 1 0.0001
409 HICCUPS 1 0.0001
410 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
411 BLOOD UREA INCREASED 2 0.0001
412 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
413 VITAMIN D DECREASED 1 0.0001
414 BLOOD MAGNESIUM DECREASED 1 0.0001
415 MUSCLE STRAIN 1 0.0001
416 SKIN SWELLING 1 0.0001
417 ORTHOSTATIC HYPOTENSION 2 0.0001
418 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
419 BLOOD CALCIUM INCREASED 1 0.0001
420 SPINAL OSTEOARTHRITIS 1 0.0001
421 GRIP STRENGTH DECREASED 1 0.0001
422 IMMUNOSUPPRESSION 1 0.0001
423 BLOOD BILIRUBIN INCREASED 3 0.0001
424 HIDRADENITIS 1 0.0001
425 PNEUMONIA BACTERIAL 1 0.0001
426 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
427 BACTERIAL INFECTION 2 0.0001
428 LEUKAEMIA 1 0.0001
429 VITAMIN D DEFICIENCY 1 0.0001
430 INFLAMMATORY BOWEL DISEASE 1 0.0001
431 HOSPICE CARE 1 0.0001
432 LIGAMENT SPRAIN 1 0.0001
433 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
434 HAEMATOCRIT DECREASED 2 0.0001
435 BRAIN INJURY 1 0.0001
436 PRODUCT DOSE OMISSION ISSUE 29 0.0001
437 DRY THROAT 1 0.0001
438 SLUGGISHNESS 1 0.0001
439 NEUTROPHIL COUNT INCREASED 1 0.0001
440 TEMPERATURE INTOLERANCE 1 0.0001
441 FEMUR FRACTURE 3 0.0001
442 PETECHIAE 1 0.0001
443 KNEE ARTHROPLASTY 2 0.0001
444 LIVER FUNCTION TEST INCREASED 2 0.0001
445 HYPOACUSIS 4 0.0001
446 SKIN CANCER 2 0.0001
447 RHINORRHOEA 6 0.0001
448 SKIN LACERATION 1 0.0001
449 PULMONARY THROMBOSIS 1 0.0001
450 DENTAL CARIES 1 0.0001
451 FISTULA 1 0.0001
452 IMPAIRED DRIVING ABILITY 1 0.0001
453 PRODUCT AVAILABILITY ISSUE 2 0.0001
454 DERMATITIS CONTACT 1 0.0001
455 MYOCARDITIS 1 0.0001
456 DRY MOUTH 7 0.0001
457 MADAROSIS 1 0.0001
458 VASCULITIS 1 0.0001
459 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
460 BLOOD IRON DECREASED 1 0.0001
461 BACTERAEMIA 1 0.0001
462 WRIST FRACTURE 1 0.0001
463 HYPERGLYCAEMIA 3 0.0001
464 SMALL INTESTINAL OBSTRUCTION 1 0.0001
465 CYST 1 0.0001
466 PRODUCT STORAGE ERROR 7 0.0001
467 SECRETION DISCHARGE 1 0.0001
468 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
469 SKIN ULCER 2 0.0001
470 INJECTION SITE INDURATION 1 0.0001
471 SWELLING FACE 5 0.0001
472 DEAFNESS 2 0.0001
473 BEDRIDDEN 1 0.0001
474 IMMUNE SYSTEM DISORDER 1 0.0001
475 DERMATITIS ATOPIC 4 0.0001
476 TOOTH INFECTION 1 0.0001
477 PULMONARY CONGESTION 1 0.0001
478 DEPRESSED MOOD 4 0.0001
479 ADVERSE REACTION 1 0.0001
480 QUALITY OF LIFE DECREASED 1 0.0001
481 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
482 ORAL DISCOMFORT 1 0.0001
483 HYPOMAGNESAEMIA 1 0.0001
484 MASS 1 0.0001
485 SEASONAL ALLERGY 1 0.0001
486 MUSCULAR WEAKNESS 8 0.0001
487 ANOSMIA 1 0.0001
488 FLUID OVERLOAD 1 0.0001
489 DYSPHONIA 4 0.0001
490 BONE PAIN 4 0.0001
491 CARDIOMYOPATHY 1 0.0001
492 PULMONARY MASS 1 0.0001
493 BLOOD POTASSIUM DECREASED 2 0.0001
494 PRODUCT QUALITY ISSUE 9 0.0001
495 THERAPEUTIC RESPONSE DECREASED 4 0.0001
496 INSURANCE ISSUE 1 0.0001
497 DRUG ADMINISTRATION ERROR 2 0.0001
498 THYROID DISORDER 1 0.0001
499 LYMPHOMA 1 0.0001
500 MUSCULOSKELETAL CHEST PAIN 1 0.0001
501 ANKLE FRACTURE 1 0.0001
502 LUNG INFECTION 1 0.0001
503 ACUTE MYELOID LEUKAEMIA 1 0.0001
504 BASAL CELL CARCINOMA 1 0.0001
505 BRAIN FOG 1 0.0001
506 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
507 MIGRAINE 6 0.0001
508 OBESITY 1 0.0001
509 SCIATICA 1 0.0001
510 HYPOTHYROIDISM 2 0.0001
511 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
512 BACK DISORDER 1 0.0001
513 PHOTOSENSITIVITY REACTION 1 0.0001
514 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
515 LIP SWELLING 2 0.0001
516 SKIN DISORDER 2 0.0001
517 CELLULITIS 3 0.0001
518 CANDIDA INFECTION 1 0.0001
519 SCAR 1 0.0001
520 EMOTIONAL DISTRESS 7 0.0001
521 RASH MACULAR 2 0.0001
522 HEART RATE DECREASED 2 0.0001
523 HYPOXIA 2 0.0001
524 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
525 LYMPHOCYTE COUNT DECREASED 1 0.0001
526 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
527 THERAPY INTERRUPTED 4 0.0001
528 THIRST 1 0.0001
529 GASTROENTERITIS VIRAL 1 0.0001
530 LEUKOCYTOSIS 1 0.0001
531 RESTLESS LEGS SYNDROME 1 0.0001
532 UNDERDOSE 4 0.0001
533 BLOOD GLUCOSE ABNORMAL 1 0.0001
534 BRONCHITIS 4 0.0001
535 HYPERSENSITIVITY 10 0.0001
536 NECK PAIN 3 0.0001
537 ERYTHEMA 11 0.0001
538 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
539 INCORRECT DOSE ADMINISTERED 12 0.0001
540 MUSCULOSKELETAL DISORDER 1 0.0001
541 FEELING JITTERY 1 0.0001
542 DRUG PRESCRIBING ERROR 1 0.0001
543 ACUTE RESPIRATORY FAILURE 1 0.0001
544 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
545 HAEMORRHOIDS 1 0.0001
546 CHOKING 1 0.0001
547 HEADACHE 32 0.0001
548 ARTHRITIS 4 0.0001
549 WHEEZING 3 0.0001
550 SINUS DISORDER 1 0.0001
551 UPPER LIMB FRACTURE 1 0.0001
552 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
553 MUSCLE SPASMS 9 0.0000
554 INSOMNIA 13 0.0000
555 HAEMOGLOBIN DECREASED 5 0.0000
556 OSTEOPOROSIS 2 0.0000
557 INJECTION SITE WARMTH 1 0.0000
558 RIB FRACTURE 1 0.0000
559 POLLAKIURIA 2 0.0000
560 SKIN EXFOLIATION 4 0.0000
561 OSTEOARTHRITIS 2 0.0000
562 GAIT DISTURBANCE 9 0.0000
563 IMPAIRED WORK ABILITY 1 0.0000
564 HYPOAESTHESIA 7 0.0000
565 IRRITABLE BOWEL SYNDROME 1 0.0000
566 BALANCE DISORDER 4 0.0000
567 PRURITUS GENERALISED 1 0.0000
568 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
569 ACUTE KIDNEY INJURY 7 0.0000
570 INTENTIONAL PRODUCT MISUSE 4 0.0000
571 MUSCULOSKELETAL STIFFNESS 4 0.0000
572 GASTROINTESTINAL DISORDER 4 0.0000
573 RASH PAPULAR 1 0.0000
574 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
575 PARAESTHESIA 7 0.0000
576 SKIN DISCOLOURATION 2 0.0000
577 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
578 OROPHARYNGEAL PAIN 4 0.0000
579 DECREASED APPETITE 10 0.0000
580 RENAL DISORDER 2 0.0000
581 COUGH 12 0.0000
582 BURNING SENSATION 3 0.0000
583 INJURY 3 0.0000
584 PRODUCT USE ISSUE 8 0.0000
585 FATIGUE 33 0.0000
586 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
587 FALL 14 0.0000
588 PRODUCT PRESCRIBING ERROR 1 0.0000
589 MULTIPLE SCLEROSIS 2 0.0000
590 BLOOD PRESSURE FLUCTUATION 1 0.0000
591 RESPIRATORY FAILURE 3 0.0000
592 FIBROMYALGIA 1 0.0000
593 DRUG INEFFECTIVE 54 0.0000
594 DYSGEUSIA 3 0.0000
595 AGEUSIA 1 0.0000
596 PNEUMONIA ASPIRATION 1 0.0000
597 HOT FLUSH 3 0.0000
598 WEIGHT DECREASED 11 0.0000
599 BACK PAIN 9 0.0000
600 RESPIRATORY TRACT INFECTION 1 0.0000
601 NERVOUSNESS 2 0.0000
602 JOINT STIFFNESS 1 0.0000
603 HYPERTENSION 8 0.0000
604 EAR INFECTION 1 0.0000
605 PLATELET COUNT DECREASED 4 0.0000
606 PAIN IN EXTREMITY 11 0.0000
607 FEAR 1 0.0000
608 OFF LABEL USE 32 0.0000
609 DIVERTICULITIS 1 0.0000
610 ARTHROPATHY 2 0.0000
611 FEELING COLD 1 0.0000
612 DEMENTIA 1 0.0000
613 WOUND 1 0.0000
614 ALOPECIA 7 0.0000
615 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
616 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
617 MYALGIA 6 0.0000
618 URINARY TRACT INFECTION 6 0.0000
619 DEPRESSION 8 0.0000
620 ANXIETY 10 0.0000
621 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
622 HERPES ZOSTER 2 0.0000
623 NEEDLE ISSUE 1 0.0000
624 DYSSTASIA 1 0.0000
625 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
626 DISEASE PROGRESSION 4 0.0000
627 DYSPNOEA 19 0.0000
628 IRRITABILITY 2 0.0000
629 SWELLING 3 0.0000
630 SWOLLEN TONGUE 1 0.0000
631 HEAD INJURY 1 0.0000
632 CYSTITIS 1 0.0000
633 METABOLIC ACIDOSIS 1 0.0000
634 MOVEMENT DISORDER 1 0.0000
635 ATRIAL FIBRILLATION 3 0.0000
636 IMPAIRED HEALING 1 0.0000
637 STAPHYLOCOCCAL INFECTION 1 0.0000
638 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
639 FUNGAL INFECTION 1 0.0000
640 SYNCOPE 3 0.0000
641 DRY SKIN 4 0.0000
642 NEOPLASM MALIGNANT 2 0.0000
643 GAIT INABILITY 1 0.0000
644 CEREBROVASCULAR ACCIDENT 5 0.0000
645 SINUSITIS 3 0.0000
646 ILLNESS 3 0.0000
647 NAUSEA 23 0.0000
648 COVID-19 5 0.0000
649 LYMPHADENOPATHY 1 0.0000
650 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
651 CONSTIPATION 6 0.0000
652 C-REACTIVE PROTEIN INCREASED 1 0.0000
653 RESTLESSNESS 1 0.0000
654 DYSURIA 1 0.0000
655 INFLUENZA 3 0.0000
656 THROMBOCYTOPENIA 3 0.0000
657 EPISTAXIS 2 0.0000
658 BLOOD GLUCOSE INCREASED 5 0.0000
659 ARTHRALGIA 11 0.0000
660 UNEVALUABLE EVENT 2 0.0000
661 COLITIS 1 0.0000
662 CHRONIC KIDNEY DISEASE 2 0.0000
663 DIABETES MELLITUS 2 0.0000
664 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
665 DIZZINESS 13 0.0000
666 PRURITUS 10 0.0000
667 PERIPHERAL SWELLING 4 0.0000
668 PALPITATIONS 3 0.0000
669 PAIN 15 0.0000
670 DRUG DOSE OMISSION 4 0.0000
671 ASTHENIA 9 0.0000
672 TOXICITY TO VARIOUS AGENTS 4 0.0000
673 RECTAL HAEMORRHAGE 1 0.0000
674 DEVICE LEAKAGE 1 0.0000
675 SEPTIC SHOCK 1 0.0000
676 MENTAL DISORDER 1 0.0000
677 ANGIOEDEMA 1 0.0000
678 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
679 ADVERSE DRUG REACTION 2 0.0000
680 THERAPY NON-RESPONDER 1 0.0000
681 SKIN IRRITATION 1 0.0000
682 ADVERSE EVENT 2 0.0000
683 BLOOD CHOLESTEROL INCREASED 1 0.0000
684 COGNITIVE DISORDER 1 0.0000
685 CARDIAC DISORDER 2 0.0000
686 NEUROPATHY PERIPHERAL 2 0.0000
687 ANAEMIA 4 0.0000
688 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
689 MALAISE 9 0.0000
690 DYSPEPSIA 2 0.0000
691 HEART RATE INCREASED 2 0.0000
692 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
693 HYPOTENSION 4 0.0000
694 FLUID RETENTION 1 0.0000
695 CHEST DISCOMFORT 2 0.0000
696 HOSPITALISATION 3 0.0000
697 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
698 INFLAMMATION 1 0.0000
699 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
700 ECZEMA 1 0.0000
701 MUSCULOSKELETAL PAIN 1 0.0000
702 SPEECH DISORDER 1 0.0000
703 PANCREATITIS 1 0.0000
704 DRUG INTERACTION 3 0.0000
705 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
706 DIARRHOEA 12 0.0000
707 PNEUMONIA 6 0.0000
708 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
709 RASH 8 0.0000
710 TREATMENT NONCOMPLIANCE 1 0.0000
711 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
712 HAEMATOCHEZIA 1 0.0000
713 MEDICATION ERROR 1 0.0000
714 SEPSIS 2 0.0000
715 PANCYTOPENIA 1 0.0000
716 BLISTER 1 0.0000
717 HYPONATRAEMIA 1 0.0000
718 SEIZURE 2 0.0000
719 MYOCARDIAL INFARCTION 3 0.0000
720 FEELING ABNORMAL 4 0.0000
721 STOMATITIS 1 0.0000
722 ILL-DEFINED DISORDER 1 0.0000
723 PLEURAL EFFUSION 1 0.0000
724 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
725 EXPOSURE DURING PREGNANCY 1 0.0000
726 DEEP VEIN THROMBOSIS 1 0.0000
727 AMNESIA 1 0.0000
728 BLOOD CREATININE INCREASED 1 0.0000
729 DEVICE DIFFICULT TO USE 1 0.0000
730 FEBRILE NEUTROPENIA 1 0.0000
731 BLOOD PRESSURE DECREASED 1 0.0000
732 DEHYDRATION 2 0.0000
733 INJECTION SITE PRURITUS 1 0.0000
734 NEUTROPENIA 2 0.0000
735 HEPATIC ENZYME INCREASED 1 0.0000
736 ABDOMINAL PAIN UPPER 3 0.0000
737 PYREXIA 5 0.0000
738 SLEEP DISORDER 1 0.0000
739 MOBILITY DECREASED 1 0.0000
740 WEIGHT INCREASED 3 0.0000
741 BLOOD PRESSURE INCREASED 2 0.0000
742 DRUG DEPENDENCE 2 0.0000
743 THROMBOSIS 1 0.0000
744 INFLUENZA LIKE ILLNESS 1 0.0000
745 TREATMENT FAILURE 1 0.0000
746 TREMOR 2 0.0000
747 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
748 URTICARIA 2 0.0000
749 ABDOMINAL DISCOMFORT 2 0.0000
750 DEVICE ISSUE 1 0.0000
751 NASOPHARYNGITIS 2 0.0000
752 CHEST PAIN 2 0.0000
753 BREAST CANCER 1 0.0000
754 DYSPHAGIA 1 0.0000
755 CONTUSION 1 0.0000
756 SOMNOLENCE 2 0.0000
757 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
758 ASTHMA 1 0.0000
759 RHEUMATOID ARTHRITIS 1 0.0000
760 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
761 JOINT SWELLING 1 0.0000
762 OEDEMA PERIPHERAL 1 0.0000
763 INJECTION SITE ERYTHEMA 1 0.0000
764 LOSS OF CONSCIOUSNESS 1 0.0000
765 RENAL FAILURE 1 0.0000
766 MEMORY IMPAIRMENT 1 0.0000
767 INFECTION 1 0.0000
768 CONDITION AGGRAVATED 2 0.0000
769 INJECTION SITE PAIN 2 0.0000
770 VOMITING 3 0.0000
771 DEATH 4 0.0000
772 OVERDOSE 1 0.0000
773 ABDOMINAL PAIN 1 0.0000